Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1918 1
1986 1
1987 1
1988 2
1989 1
1994 2
1995 1
1997 2
1998 1
2004 1
2007 3
2010 1
2012 3
2013 2
2014 2
2015 2
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial.
Smith MR, Scher HI, Sandhu S, Efstathiou E, Lara PN Jr, Yu EY, George DJ, Chi KN, Saad F, Ståhl O, Olmos D, Danila DC, Mason GE, Espina BM, Zhao X, Urtishak KA, Francis P, Lopez-Gitlitz A, Fizazi K; GALAHAD investigators. Smith MR, et al. Lancet Oncol. 2022 Mar;23(3):362-373. doi: 10.1016/S1470-2045(21)00757-9. Epub 2022 Feb 4. Lancet Oncol. 2022. PMID: 35131040 Free PMC article. Clinical Trial.
Treatment of bicalutamide-induced breast events.
Sieber PR. Sieber PR. Expert Rev Anticancer Ther. 2007 Dec;7(12):1773-9. doi: 10.1586/14737140.7.12.1773. Expert Rev Anticancer Ther. 2007. PMID: 18062751 Review.
Sarcoidosis and testicular tumors.
Sieber PR, Duggan FE. Sieber PR, et al. Urology. 1988 Feb;31(2):140-1. doi: 10.1016/0090-4295(88)90040-4. Urology. 1988. PMID: 2448942
Phase Ib/II Study of Enzalutamide with Samotolisib (LY3023414) or Placebo in Patients with Metastatic Castration-Resistant Prostate Cancer.
Sweeney CJ, Percent IJ, Babu S, Cultrera JL, Mehlhaff BA, Goodman OB, Morris DS, Schnadig ID, Albany C, Shore ND, Sieber PR, Guba SC, Zhang W, Wacheck V, Donoho GP, Szpurka AM, Callies S, Lin BK, Bendell JC. Sweeney CJ, et al. Among authors: sieber pr. Clin Cancer Res. 2022 Jun 1;28(11):2237-2247. doi: 10.1158/1078-0432.CCR-21-2326. Clin Cancer Res. 2022. PMID: 35363301 Free PMC article. Clinical Trial.
Sarcopenia during androgen-deprivation therapy for prostate cancer.
Smith MR, Saad F, Egerdie B, Sieber PR, Tammela TL, Ke C, Leder BZ, Goessl C. Smith MR, et al. Among authors: sieber pr. J Clin Oncol. 2012 Sep 10;30(26):3271-6. doi: 10.1200/JCO.2011.38.8850. Epub 2012 May 29. J Clin Oncol. 2012. PMID: 22649143 Free PMC article. Clinical Trial.
26 results